Aligos Therapeutics (ALGS) Net Margin (2019 - 2026)
Aligos Therapeutics' Net Margin came in at -814.13% for Q1 2026, down 14668.80 percentage points from 13854.66% a year earlier but up 10949.77 percentage points from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Net Margin (2019 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Net Margin was -1106.72%, up 2526.92 percentage points from FY2024.
- Net Margin carries a four-year change of +1837.35 percentage points (FY2021 to FY2025).
- Going back by year, Net Margin was -3633.65% in FY2024 (-2694.70 pp), -938.95% in FY2023 (-248.32 pp), -690.63% in FY2022 (+2253.44 pp) and -2944.07% in FY2021.
- The five-year range for quarterly Net Margin is -13556.11% (Q4 2024) to 13854.66% (Q1 2025).
- Year-over-year, Net Margin increased in three of the last eight quarters, with an average year-over-year change of -1348.86 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q1 2025 (a gain of 18878.15 percentage points), and the weakest in Q1 2026 (a drop of 14668.80 percentage points).
- Business Quant data shows ALGS's Net Margin at -11763.91% (Q4 2025), -4256.01% (Q3 2025) and -1643.83% (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -1.65% |
| 10 | Aligos Therapeutics | 53.51 Mn | -274.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -814.13% |
| Dec 31, 2025 | -11,763.91% |
| Sep 30, 2025 | -4,256.01% |
| Jun 30, 2025 | -1,643.83% |
| Mar 31, 2025 | 13,854.66% |
| Dec 31, 2024 | -13,556.11% |
| Sep 30, 2024 | -1,540.72% |
| Jun 30, 2024 | 477.00% |
| Mar 31, 2024 | -5,023.49% |
| Dec 31, 2023 | -1,388.35% |
| Sep 30, 2023 | -837.56% |
| Jun 30, 2023 | -437.61% |
| Mar 31, 2023 | -888.70% |
| Dec 31, 2022 | -618.77% |
| Sep 30, 2022 | -453.51% |
| Jun 30, 2022 | -539.51% |
| Mar 31, 2022 | -1,385.26% |
| Dec 31, 2021 | -10,276.29% |
| Sep 30, 2021 | -2,155.11% |
| Jun 30, 2021 | -1,929.97% |
API Access
Aligos Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();